When standard antidepressants don't work, people with treatment-resistant depression face tough choices about what to try next. Many hope that getting the specific treatment they prefer—whether it's a medication or a brain stimulation therapy—will give them a better shot at feeling better. But a fresh look at data from a clinical trial suggests that might not be the case.
The study involved 256 adults whose depression hadn't responded to standard treatment. They were randomly assigned to receive one of three different treatments. Before starting, researchers asked them which treatment they preferred. Later, they looked at how much people's depression scores improved. The key finding? The amount of improvement was essentially the same, whether someone got the treatment they wanted, had no strong preference, or even received a treatment they didn't want.
It's important to understand what this does and doesn't mean. This was a secondary analysis, meaning the researchers went back to look at existing trial data with a new question. The analysis found no significant link between preference and outcome. This doesn't mean patient choice is unimportant—feeling heard and having a say in your care is always valuable. But it suggests that, for this group of patients, the specific biological effect of the treatment itself might be a stronger factor in whether it works than simply wanting it to work. The study wasn't designed to prove cause and effect from the start, so we can't draw firm conclusions yet.